Acabrunat 100mg Capsule 30's

Acabrunat 100mg Capsule Overview for Hospitals

Acabrunat 100mg Capsule contains Acalabrutinib, used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). It works by inhibiting Bruton's tyrosine kinase (BTK) to block cancer cell growth. The recommended dose is 100mg orally twice daily, with regular monitoring for blood counts and liver function. Common side effects include anemia, neutropenia, headache, diarrhea, and infections, while serious effects may involve bleeding or heart issues.

Acabrunat 100mg Uses in Oncology

Acabrunat 100mg Capsule is primarily used in oncology antineoplastic products  to treat hematologic cancers. It is indicated for mantle cell lymphoma (MCL) in patients who have received prior therapy, as well as...